Judgment of the General Court (Seventh Chamber) of 7 March 2013.#Acino AG (formerly Acino Pharma GmbH) v European Commission.#Medicinal products for human use — Suspension of the placing on the market and withdrawal of medicinal products containing the active ingredient Clopidogrel — Variation of the authorisation to place on the market — Prohibition from placing medicinal products on the market — Regulation (EC) No 726/2004 and Directive 2001/83/EC — Proportionality — Obligation to state reasons.#Case T‑539/10.

Judgment of the General Court (Seventh Chamber) of 7 March 2013.
Acino AG (formerly Acino Pharma GmbH) v European Commission.
Medicinal products for human use — Suspension of the placing on the market and withdrawal of medicinal products containing the active ingredient Clopidogrel — Variation of the authorisation to place on the market — Prohibition from placing medicinal products on the market — Regulation (EC) No 726/2004 and Directive 2001/83/EC — Proportionality — Obligation to state reasons.
Case T‑539/10.

Judgment of the General Court (Seventh Chamber) of 7 March 2013.
Acino AG (formerly Acino Pharma GmbH) v European Commission.
Medicinal products for human use — Suspension of the placing on the market and withdrawal of medicinal products containing the active ingredient Clopidogrel — Variation of the authorisation to place on the market — Prohibition from placing medicinal products on the market — Regulation (EC) No 726/2004 and Directive 2001/83/EC — Proportionality — Obligation to state reasons.
Case T‑539/10.

European Court Reports 2013 -00000

ECLI identifier: ECLI:EU:T:2013:110